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 High throughput analysis and large scale integration of biological data led to 
leading researches in the field of bioinformatics. Recent years witnessed the 
development of various methods for disease associated gene prediction and 
disease comorbidity predictions. Most of the existing techniques use 
network-based approaches and similarity-based approaches for these 
predictions. Even though network-based approaches have better 
performance, these methods rely on text data from OMIM records and 
PubMed abstracts. In this method, a novel algorithm (HDCDGP) is proposed 
for disease comorbidity prediction and disease associated gene prediction. 
Disease comorbidity network and disease gene network were constructed 
using data from gene ontology (GO), human phenotype ontology (HPO), 
protein-protein interaction (PPI) and pathway dataset. Modified random walk 
restart algorithm was applied on these networks for extracting novel disease-
gene associations. Experimental results showed that the hybrid approach has 
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Disease comorbidity is defined as the existence of multiple disorders together with a primary disease 
[1]. This can add to the complexity of the treatment procedure and the condition of co-morbid patients is 
more complicated than that of patients suffering from any single disease. Comorbidity raises the difficulty of 
treating diseases that may potentially lead to higher mortality rates. Patients suffering from comorbid disease 
conditions need appropriate medical care and attention. Comorbidity can depend on pre-existing conditions 
or may exist as distinct conditions [2]. Though many diseases are comorbid, the underlying biological 
reasons remain obscured. Analyzing comorbid disease conditions by examining etiological components helps 
in discovering the basis mechanisms behind the development of diseases. Common genes, pathways and 
protein-protein interactions are biological factors contributing to disease comorbidities. The study of disease 
comorbidity can reveal the basic molecular disease mechanisms. This in turn can be useful for pinpointing 
disease causing genes and the associated biological pathways or vice-versa. Numerous research works have 
now been carried out on the basis of clinical data as well as molecular data for predicting disease comorbidities. 
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Most of these works rely on data mining techniques [3] for predicting novel comorbidities. Table 1 shows some of 
the existing systems available for disease comorbidity prediction. 
Network approach based on random walks and statically approaches were mainly used for disease 
comorbidity prediction. A combination of statistical and network approach was also found to be effective in 
disease comorbidity prediction [4]-[6]. Another method, frequent pattern mining has also shown good 
performance for pattern analysis from outpatient records [7]. Post market adverse drug surveillance data was 
also used for comorbidity prediction [8]. 
 
 
Table 1. Existing systems for disease comorbidity predictions 
Existing System Techniques Used Limitations 
ComoR [9] Statistical approach (Relative 
Risk and ϕ-correlation) 
− Did not consider PPI and Pathway data 
“Identification of disease 
comorbidity through hidden 
molecular mechanisms” [10] 
Network-based approach 
(Random Walk Restart 
algorithm and XD Score) 
− Protein-protein interaction data was not considered which 
also could contribute in detecting disease comorbidities.  
− Clinical data-based test was not conducted 
Comorbidity [11] Network-based approach 
(Random Walk Restart 
algorithm) 
− Did not consider PPI and Pathway data 
“Finding disease similarity 
based on implicit semantic 
similarity” [12] 
Semantic similarity using GO 
terms 
− Causal factors not considered 
− Impossible to discriminate the primary disease and the 
comorbid disease 
PCID [1] Similarity based approach − The pathway information considered was limited to the 
current knowledge on molecular pathways, and more 
signals may be discovered if the PPI network was used 
instead of current pathway annotations.  
− When the multi-view similarity was integrated based on 
different types of data, contribution from each data was 
assumed to be equal.  
− Disease comorbidities exist in a condition-specific 
manner. Data contributing to this fact like age and sex 
was not considered during the development of PCID. 
CORE [13] Clustering and Association 
Analysis 
− Considered only past medical history of patients  
− Did not consider current symptoms and clinical or 
biological factors 
− Dataset was small 
 
 
Most of the existing systems, consider only one or two biological factors underlying the comorbidity 
patterns such as genes, pathways, biological process, cellular component, protein-protein interaction and 
molecular functions for disease comorbidity prediction. Integration of these data helps in increasing the predictive 
power of prediction methods. Latest researches in disease comorbidity prediction was successful in integrating 
multi-scale dataset. But all the datasets were given equal weightage while making comorbidity predictions.  
In this work, a dataset ranking algorithm has been used for finding the relevance of each dataset in 
comorbidity prediction. Using weighted association rule mining, disease comorbidity patterns were 
generated. CTD [14] database contains information on disease-gene associations, disease-pathway 
associations and phenotype-disease interactions. These information were mainly used for disease comorbidity 
prediction. Additional databases used in this work is discussed in the next section. 
 
 
2. DATASET USED 
Three types of data have been considered: PPI, Pathway and Gene Ontology annotations in the 
proposed method. PPI data were downloaded from MINT [15], HPRD [16] and IntAct [17]. CTD and 
DisGeNet [18] databases were used for obtaining disease-gene associations. A total of 39239 PPI were taken 
for conducting experiment and a maximum of up to 234 diseases were found to be associated with each PPI. 
The two main sources of dataset for disease-pathway information has been: “Molecular Signatures 
DataBase” (MSigDB) 4.0 and CTD. A set of 1077 pathways were obtained from “curated(c2) gene sets” in 
MSigDB V4.0.About 551548 pathways were taken from CTD database. For the task of association rule 
mining, a transaction corresponds to a pathway in the pathway database and the diseases related to the 
pathway were considered as data items belonging to the respective transaction. A total of 2332 pathways 
were found to have “comorbid disease conditions” associated with them. CTD database contains “diseases- 
GO annotations” mappings that can be directly extracted for mining task. There are 118773 associations 
between diseases and GO cellular components, 145579 associations between Diseases and GO molecular 
function and 671095 associations between diseases and GO biological process. 
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3. PROPOSED METHOD 
The overall architecture of the system is shown in Figure 1. In the existing available system for 
disease comorbidity prediction using diverse dataset, similarity based approach was used. The disadvantage 
of this technique is that all the datasets were given equal weightage or their contribution in comorbidity 
prediction was assumed to be equal. To overcome this disadvantage, we introduced a dataset ranking 
algorithm [19] which is based on multi-criteria decision analysis. Three different data set were considered: 
protein-protein interaction (PPI) data, Pathway data and gene ontology (GO) [20], [21] annotation data. Since 
these datasets are diverse in nature, their contribution in comorbidity prediction will be different. So there 
exists the need to evaluate the dataset based on their contribution in comorbidity prediction.  
Multi-criteria decision analysis approach was chosen for ranking datasets. Multi-criteria decision 
analysis is a ranking method that is commonly used to arrange a finite number of decision alternatives, each 
of which is clearly described in terms of different characteristics. These characteristics are also often called 
attributes or decision criteria. Selection of criteria for decision analysis is purely based on user requirement. 
Accuracy of a system is defined in terms of true positive, true negative, false positive and false negative 
values. Since we are focusing on accuracy of prediction, the decision criteria considered for dataset ranking 
are true positive, true negative, false positive and false negative values. Out of these, true positive and true 
negative values are more relevant since they directly contribute to the expected results for prediction whereas 
false values have no direct contribution to prediction results. They are only used for finding accuracy. These 
values are calculated using existing approach [1] based on similarity measurement. Pathway dataset is ranked 





Gene Ontology Annotations-D3, 
Primary Disease PD, Query Disease QD, 
Performance Parameters-TP, TN, FN 
Associated weights W1, W2, W3 as 3, 2, 1 for TP,  
                           TN and FN respectively 
Steps: 
Calculate disease similarity between PD and QD using D1, D2, D3 
for i in 1 to 3 
find TP(Di), TN(Di), FN(Di) 
for i in 1 to 3 
𝐶(𝐷𝑖, 𝐷𝑗) =
∑ ∀𝑗: 𝑔(𝐷𝑖) ≥ 𝑔(𝐷𝑗)𝑊𝑗
∑ 𝑊𝑛𝑗=1 𝑗
 
𝐼𝑓 ∀𝑥 𝑔𝑥(𝐷𝑖) ≥ 𝑔𝑥(𝐷𝑗)𝑡ℎ𝑒𝑛 





𝑚𝑎𝑥[𝑔𝑦(𝐷𝑗) − 𝑔𝑦(𝐷𝑖)] 
𝐼𝑓 𝐶(𝐷𝑖, 𝐷𝑗) ≥ 𝐶𝑡 𝑎𝑛𝑑 𝐷(𝐷𝑖, 𝐷𝑗))  ≤ 𝑑𝑡 𝑡ℎ𝑒𝑛 
Di outperforms Dj; 
Rank 𝐷𝑖 accordingly with the highest weight Wx. 
 
After ranking the dataset, weighted association rule mining was performed for generating disease 
comorbidities. In the next phase, disease comorbidities were generated using network-based method. 
Network based approaches are usually used for the prediction of disease associated genes. Variants of 
random walk restart (RWR) algorithm are applied for finding disease associated genes from disease-gene 
networks. RWR starts randomly from a seed node to another, but can also restart the navigation in a new 
arbitrary node. Thereby, depending on the topological structure of the network, some nodes will be visited 
more frequently than others. The number of visits is considered as a proxy measure of relevance of each node 
with respect to seed node. In our work, instead of directly using disease network and gene network, HPO [22] 
and GO annotations were used for constructing network. GO annotations and HPO annotations were 
downloaded from gene ontology and human phenotype ontology. Using weighted association rule mining, 
GO term associations and HPO term associations were obtained [23]-[26]. Two networks were constructed; 
one containing nodes of GO terms and other having nodes of HPO terms. These two networks were then 
connected using known GO-HPO associations. Thus a bipartite graph was formed. Then a modified random walk 
was performed on this bipartite graph to generate novel disease-gene correlation and disease comorbidities [27]. 
Rules generated in the first two phases were combined to generate comorbidity network with nodes, 
diseases and genes. A query disease and target disease were given as input to the system. Then a query-
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disease vector and target-disease vector were generated with known disease-gene association. RWR was 
repeatedly performed on the hybrid network with query disease as seed node and restart probability of 0.8. 





Figure 1. Overall system architecture 
 
 
Algorithm for the proposed method is given below: 
 
HDCDGP Algorithm 
Input: PPI Data, Pathway Data, GO Annotations, HPO Annotations, Query Disease 
Output: Novel disease comorbidities and gene-disease associations 
Steps: 
1. Start 
2. Collecting PPI data, Pathway data and Gene Ontology data from PPI and CTD databases 
3. Ranking the dataset based on multi-criteria decision analysis using ELECTRE – I method 









6. Calculate valence weight as 
 
𝑉𝑘 = 𝛿.  𝑃𝑘 + (1 − 𝛿) ∑
𝑐𝑜𝑢𝑛𝑡(𝑖𝑘)
𝑐𝑜𝑢𝑛𝑡(𝑘)
 .  𝑃𝑖
𝑛
𝑖   
 
7. Define weighted support as the product of dataset rank and valence weight 
8. Weighted Association rule mining is performed to generate novel disease comorbidities 
9. Perform weighted association rule mining in Gene Ontology to generate GO term associations. 
10. Perform weighted rule mining in HPO to generate HPO term associations. 
11. Generate GO network and HPO network based on the association rules.  
12. Combine the networks using known GO-HPO associations to generate a bi-partite graph. 
13. Apply random walk restart algorithm to obtain novel disease-gene correlation. 
14. Construct a hybrid network with edges that are associations of the form disease-disease, disease-gene and 
gene-gene. 
15. A disease vector is generated for query disease with known disease-gene interactions. 
16. Perform random walk on the hybrid network with a restart probability of 0.8. 
17. Generate disease vectors for target diseases. 
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18. Compute cosine similarity as  
 


















4. RESULTS AND DISCUSSION 
The network statics of the hybrid network is given in Table 2. Figures 2 to 7 demonstrates the 
comparison of various network parameters of the resultant network (graph) generated using Cytoscape [28]. 
From Figure 2, it can be seen that the maximum number of shared neighbors is less than 20. The shortest path 
length distribution in Figure 3 gives the number of node pairs (n, m) with various shortest path length. The 
graph shows that shortest path length of 4 is maximum for a frequency of 400000. Closeness centrality is 
another network parameter that describes how fast a node can be approached (reachable) from other nodes. It 
is the inverse of average shortest path length. Figure 4 depicts closeness centrality versus number of 
neighbors. Node degree distribution gives the number of edges connected to a given node. Figure 5 shows the 
node degree distribution of the resultant graph. If a node is connected to more number of nodes, the 
comorbidity information related to that node may be less accurate; since the number of such nodes are less as 
evident from the graph, the comorbidity information is more reliable. Figure 6 illustrates the neighborhood 
connectivity distribution of the graph. The neighborhood connectivity of a node is the average connectivity of 
all neighbors of that node and the neighborhood connectivity distribution gives the average of the 
neighborhood connectivities of all nodes in the given graph.  
 
 
Table 2. Network statistics 
Parameter Value 
Clustering Coefficient 0.154 
Connected Components 81 
Network Centralization 0.113 
Average number of neighbors 11.756 
Number of Nodes 10014 
Network Density 0.001 
Network Heterogeneity 1.878 
Number of self-loops 1 
Multi-edge node pairs 2 





Figure 2. Shared neighbors’ distribution 
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Clustering coefficient of a node n is defined as: 
Cn=2en/(kn (kn-1)), where kn is the number of neighbors of n and en is the number of connected 
pairs between all neighbors of n. Figure 7 illustrates the average clustering coefficient distribution of the 
graph. 81 connected components are present in the resultant graph. 
Case Study: MESH: D000544 (Alzheimer’s disease)  
Comorbid conditions associated with Alzheimer’s disease were studied in detail. There were about 
663 pathways found to be associated with Alzheimer’s disease. 1824 biological processes, 324 cellular 
components and 493 molecular functions in gene ontology were found to be associated with Alzheimer’s 
disease. Tables 3, 4, 5 and 6 show the comorbidity supporting statistics of Alzheimer’s disease with 










Figure 4. Closeness centrality 
 
 
For evaluating the performance of proposed method, a gold standard set of 14 diseases were chosen: 
HP:0100615 (Ovarian Cancer), HP:0001658 (Myocardial Infarction), HP:0001250 (Epilepsy), HP:0002511 
(Alzheimer’s Disease), HP:0000822 (Hypertension), HP:0002099 (Asthma), HP:0002665 (Lymphoma), 
HP:0001638 (Cardiomyopathy), HP:0000821 (Hypothyroidism), HP:0001875 (Neutropenia), HP:0000726 
(Dementia), HP:0001370 (Rheumatoid arthritis), HP:0001909 (Leukemia), HP:0001677 (Coronary artery disease).  
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Figure 7. Average clustering coefficient distribution 
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Table 3. Alzheimer’s disease-comorbidity statistics 
based on cellular components 
Comorbid 
Disease 








































Table 4. Alzheimer’s disease-comorbidity statistics 
based on molecular functions 
Comorbid 
Disease 









































To validate the performance Leave one out cross validation (LOOCV) is applied. The ROC curve 
is given in Figure 8. To avoid mismatch in disease id as different datasets follow different ID for the same 
disease, MESH ID was chosen in common. The area under curve (AUC) for the ROC curve given in Figure 8 was 
calculated which turned up to 0.853. Figure 9 illustrates the performance comparison of proposed method 
with existing approaches: PCID [1], VBWARCP [19], OBDCP [27]. 
 
 
Table 5. Alzheimer’s disease-comorbidity statistics based on biological process in gene ontology 
Comorbid Disease 
Number of common biological 
process (GO Terms) 
Examples of common 
Biological Process (GO Terms) 
PMID 
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Table 6. Alzheimer’s disease-comorbidity statistics based on pathways 
Comorbid Disease Number of common pathways Examples of common pathways 





























Figure 8. ROC curve Figure 9. Performance comparison 
 
 
In this work, we have developed a weighted association rule mining method for discovering disease 
comorbidities from heterogeneous forms of dataset. By implementing a dataset ranking algorithm, the 
performance of algorithm on various datasets like protein-protein interaction (PPI) data, pathway data and 
gene ontology dataset were studied. Rather than providing the datasets the same weightage, PPI dataset is 
given the highest rank, based on multi-criteria decision analysis. This could help in increasing the accuracy of 
predicting disease comorbidities. Valence based weighted association rule mining for disease comorbidity 
prediction (VBWARCP) algorithm has been developed based on weighted Apriori algorithm by introducing 
weights in terms of dataset rank, purity and linkage. VBWARCP has got an accuracy of 79%.  
In the second phase, a bipartite network is developed with terms from gene ontology (GO) and 
human phenotype ontology (HPO). Gene ontology terms were connected using associations obtained from 
gene ontology by applying weighted association rule mining algorithm. Similarly, HPO terms were 
connected using associations among HPO terms derived as association rules. These rules were generated 
from human phenotype ontology by means of weighted association rule mining. Then the terms in Gene 
Ontology were mapped to terms in human phenotype ontology terms using known associations. These 
relationships were extracted from human phenotype ontology (HPO). HPO website contains HPO-gene 
associations. Thus an ontology based system for disease-comorbidity prediction (OBDCP) was developed. 
Application of random walk restart on heterogeneous network (RWRH) on the resultant network helps in 
finding disease comorbidities as well as disease associated genes. Accuracy of OBDCP was around 77%. 
Though it was less than the accuracy of VBWARCP, it was higher than the accuracy of similarity based 
approach. 
Int J Elec & Comp Eng  ISSN: 2088-8708  
 
Hybrid approach for disease comorbidity and disease gene prediction… (Lakshmi K. S.) 
5249 
Using the patterns and associations obtained in the first two phases, a comorbidity network has been 
constructed. The network consists of disease-disease edges (using known disease-disease associations and the 
result obtained using VBWARCP and OBDCP), gene-gene edges (constructed using PPI data) and disease-
gene edges (constructed using already known gene-disease associations and those obtained using OBDCP). If 
a medical record is given as input to this system, medical terms can be extracted and the resultant diseases 
can be given as query diseases and the comorbid diseases associated with a patient can be found. It is also 
possible to find the genes associated with the query disease. 
 
 
5. CONCLUSION  
HDCDGP presents a reliable method to study disease comorbidities that can be suggested for high-
throughput and clinical data analysis. Causal inference of diseases can be learned by the analysis of disease 
comorbidities and disease gene associations. Compared to the existing systems, our approach has gained an 
overall accuracy of 85%. HDCDGP is capable of finding novel disease comorbidities as well as disease-gene 
correlation. This approach will guide the researchers in improved understanding of the complex pathogenesis 
of disease risk phenotypes and the heterogeneity of diseases.  
Discovering associations among diseases provides a deep cognizance on the underlying causes of 
diseases and assists in the task of disease-associated gene prediction and also in the development of novel 
drugs. Since associations among genes are not the only factor contributing to disease comorbidities, 
information of common pathways and abnormalities in cellular components, biological processes and 
metabolic functions in genes in detecting comorbid diseases will increase the prediction accuracy. If doctors 
are aware of the possibility of various comorbid disease conditions, it could help them in choosing treatment 
methods and also alleviates the sufferings that the patients may undergo. The proposed model can be further 
expanded by considering miRNA expressions. Adding more molecular level information will help in 
increasing the accuracy as well as discovering novel comorbidities. The system can also be used for 
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